Pliant Therapeutics, Inc.

PLRX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$26-$43-$56-$50
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$6$9$8
Change in WC-$2-$7-$4-$8
Other Non-Cash$7$3$2$1
Operating Cash Flow-$21-$41-$49-$48
Investing Activities
PP&E Inv.$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$52-$14-$33
Inv. Sales/Matur.$0$87$84$73
Other Inv. Act.$28$0$0$0
Investing Cash Flow$28$35$69$39
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash$7-$5$21-$8
Supplemental Information
Beg. Cash$88$93$71$81
End Cash$95$88$92$73
Free Cash Flow-$21-$41-$49-$48
Pliant Therapeutics, Inc. (PLRX) Financial Statements & Key Stats | AlphaPilot